Paula Mohyi
Allergy & Immunology · Falls Church, VANPI 1225526585
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AstraZeneca at 26.5% of the total. 2025 is the largest year on record at $1,852, 3.9 times the $472 reported in 2021.
Across 149 payments — averaging $33.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$610
- Sanofi$532
- Pfizer$392
- ARS Pharmaceuticals Operations, Inc.$318
- Amgen$301
- plus $1K from 19 others
What the payments were for
- Consulting fees$461%
- Food & beverage$4,91099%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 32 | $1,313 |
| GSK | 22 | $610 |
| Sanofi | 15 | $532 |
| Pfizer | 10 | $392 |
| ARS Pharmaceuticals Operations, Inc. | 12 | $318 |
| Amgen(2 entities) | 8 | $301 |
| Novartis | 12 | $245 |
| Regeneron Healthcare Solutions, Inc. | 9 | $237 |
| Grifols USA, LLC | 1 | $152 |
| Alk-abello, Inc | 1 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $116 |
| Pharming Healthcare, Inc. | 1 | $114 |
| Genentech USA, Inc. | 4 | $109 |
| Biocryst US Sales Co., LLC | 2 | $62 |
| Phadia US Inc. | 3 | $55 |
| ADMA Biomanufacturing LLC | 3 | $46 |
| Kaleo, Inc. | 1 | $32 |
| AbbVie | 1 | $30 |
| Ionis Pharmaceuticals, Inc. | 1 | $30 |
| CSL Behring | 1 | $28 |
| Boehringer Ingelheim | 1 | $24 |
| Genentech, Inc. | 1 | $22 |
| Merck | 1 | $22 |
| GC Biopharma USA, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,955 in reported general payments places this provider in the 55th percentile of 133 allergy & immunology providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 12 | $225 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Falls Church
- Charles LaneLynchburg$1.4M
- Jacqueline Eghrari-SabetVienna$1M
- Eric KarlinWilliamsburg$522K
- Nicholas RiderRoanoke$227K
- Courtney BlairMc Lean$139K
- Andrew KimFredericksburg$104K
- Behnam DaghighLeesburg$99K
- Ananth ThyagarajanBurke$97K
- Larry BorishCharlottesville$92K
- Oral AlpanSpringfield$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.